Advertisement

Topics

Kite Announces Commencement of Public Offering of Common Stock

06:40 EST 2 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Kite Pharma, Inc. (Nasdaq: KITE) today announced the commencement of an underwritten public offering of 4,750,000 shares of its common stock. In addition, Kite has granted the underwriters of the offering a 30-day option to purc...

Other Sources for this Article

Kite Pharma, Inc.
Christine Cassiano
SVP, Corporate Communications & Investor Relations
ccassiano@kitepharma.com
or
Greg Mann
VP, Investor Relations
gmann@kitepharma.com

NEXT ARTICLE

More From BioPortfolio on "Kite Announces Commencement of Public Offering of Common Stock"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...